![Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder? | Child and Adolescent ... Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder? | Child and Adolescent ...](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1753-2000-3-39/MediaObjects/13034_2009_Article_95_Fig1_HTML.jpg)
Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder? | Child and Adolescent ...
![Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies | BMC Psychiatry | Full Text Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies | BMC Psychiatry | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-244X-13-237/MediaObjects/12888_2013_Article_1428_Fig5_HTML.jpg)
Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies | BMC Psychiatry | Full Text
![Z-Score Neurofeedback and Heart Rate Variability Training for Adults and Children with Symptoms of Attention-Deficit/Hyperactivity Disorder: A Retrospective Study | SpringerLink Z-Score Neurofeedback and Heart Rate Variability Training for Adults and Children with Symptoms of Attention-Deficit/Hyperactivity Disorder: A Retrospective Study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10484-019-09439-x/MediaObjects/10484_2019_9439_Fig3_HTML.png)
Z-Score Neurofeedback and Heart Rate Variability Training for Adults and Children with Symptoms of Attention-Deficit/Hyperactivity Disorder: A Retrospective Study | SpringerLink
Medication changes after switching from CONCERTA® brand methylphenidate HCl to a generic long-acting formulation: A retrospective database study
![Comparative efficacy of Concerta®(18, 36 mg) and Ritalin LA®(20 mg)... | Download Scientific Diagram Comparative efficacy of Concerta®(18, 36 mg) and Ritalin LA®(20 mg)... | Download Scientific Diagram](https://www.researchgate.net/profile/Antonella-Gagliano-2/publication/257202727/figure/fig3/AS:202535299227650@1425299586196/Comparative-efficacy-of-ConcertaR18-36mg-and-Ritalin-LAR20mg-versus-placebo-in-a.png)
Comparative efficacy of Concerta®(18, 36 mg) and Ritalin LA®(20 mg)... | Download Scientific Diagram
![Concerta (Methylphenidate Extended-Release Tablets): Uses, Dosage, Side Effects, Interactions, Warning Concerta (Methylphenidate Extended-Release Tablets): Uses, Dosage, Side Effects, Interactions, Warning](https://images.rxlist.com/images/rxlist/methylphen2.gif)
Concerta (Methylphenidate Extended-Release Tablets): Uses, Dosage, Side Effects, Interactions, Warning
![A Post Hoc Comparison of Prior ADHD Medication Dose and Optimized Delayed-release and Extended-release Methylphenidate Dose in a Pivotal Phase III Trial - Clinical Therapeutics A Post Hoc Comparison of Prior ADHD Medication Dose and Optimized Delayed-release and Extended-release Methylphenidate Dose in a Pivotal Phase III Trial - Clinical Therapeutics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/cd79fc5b-e9c0-4aa3-9cbb-4a787f06e654/gr1.jpg)
A Post Hoc Comparison of Prior ADHD Medication Dose and Optimized Delayed-release and Extended-release Methylphenidate Dose in a Pivotal Phase III Trial - Clinical Therapeutics
![Individualization of attention-deficit/hyperactivity disorder treatment: pharmacotherapy considerations by age and co-occurring conditions | CNS Spectrums | Cambridge Core Individualization of attention-deficit/hyperactivity disorder treatment: pharmacotherapy considerations by age and co-occurring conditions | CNS Spectrums | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20210622083539525-0708:S1092852919001822:S1092852919001822_tab3.png?pub-status=live)
Individualization of attention-deficit/hyperactivity disorder treatment: pharmacotherapy considerations by age and co-occurring conditions | CNS Spectrums | Cambridge Core
![Mixed amphetamine salts extended release: a clinical review of its use in the treatment of attention-deficit hyperactivity disorder | Future Neurology Mixed amphetamine salts extended release: a clinical review of its use in the treatment of attention-deficit hyperactivity disorder | Future Neurology](https://www.futuremedicine.com/cms/10.2217/14796708.1.5.525/asset/images/medium/graphic22.gif)
Mixed amphetamine salts extended release: a clinical review of its use in the treatment of attention-deficit hyperactivity disorder | Future Neurology
![PDF) Comparison of the Efficacy of Two Different Modified Release Methylphenidate Preparations for Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a Natural Setting: Comparison of the Efficacy of Medikinet ® Retard and PDF) Comparison of the Efficacy of Two Different Modified Release Methylphenidate Preparations for Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a Natural Setting: Comparison of the Efficacy of Medikinet ® Retard and](https://www.researchgate.net/profile/Andre-Scherag/publication/51522238/figure/fig2/AS:601229885464587@1520355783514/DAYAS-daily-course-mean-values-in-children-with-ADHD-treated-with-the-three_Q320.jpg)
PDF) Comparison of the Efficacy of Two Different Modified Release Methylphenidate Preparations for Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a Natural Setting: Comparison of the Efficacy of Medikinet ® Retard and
![Stimulant Equivalency Table --- Matt Swenson, MD / stimulant-equivalency-table-matt-swenson-md.pdf / PDF4PRO Stimulant Equivalency Table --- Matt Swenson, MD / stimulant-equivalency-table-matt-swenson-md.pdf / PDF4PRO](https://pdf4pro.com/cache/preview/5/c/4/8/9/1/1/6/thumb-5c489116a3f3229b8208409055015867.jpg)